New BIO Survey Counters Claims Regarding Single Source Therapies in Medicare Part D (Business Wire via Yahoo! Finance)
WASHINGTON----The Biotechnology Industry Organization today released a study which found that Medicare Part D plans offer significant discounts on single-source therapies and provide greater access to many single-source innovative therapies not available through the Department of Veterans Affairs pharmacy benefit or mail-order pharmacies such as Costco.com and drugstore.com.

PCMA: PBMs Negotiating Lower Drug Prices in Medicare Part D (U.S. Newswire via Yahoo! News)
New government data estimating that Medicare prescription drug plans sharply reduced the rate of growth in prescription-drug prices in 2006 affirms the central role of pharmacy management tools in Part D and serves as a timely reminder to policymakers that Part D is working as Congress intended, the Pharmaceutical Care Management Association (PCMA) said today.